Ross Osborn

Stock Analyst at Cantor Fitzgerald

(0)
# 3327
Out of 5,240 analysts
103
Total ratings
34.12%
Success rate
1.82%
Average return
24 Stocks
Name Action Price Target Current % Upside Ratings Updated
Exagen
Reiterates: Overweight
8 8
3.02 164.9% 5 Jan 13, 2025
Anteris Technologies
Initiates Coverage On: Overweight
9
5.63 59.86% 1 Jan 7, 2025
AVITA Medical
Reiterates: Overweight
21 21
8.89 136.22% 10 Dec 24, 2024
Nano X Imaging
Maintains: Overweight
11 12
7.47 60.64% 10 Dec 6, 2024
Prenetics Global
Reiterates: Overweight
9 9
5.81 54.91% 6 Dec 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 2
0.81 146.91% 4 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
10 10
3 233.33% 9 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
16 16
9.32 71.67% 4 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
14 14
16.17 -13.42% 2 Oct 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
96
95.83 0.18% 1 Oct 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
18 18
11.92 51.01% 4 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
4 4
1.84 90.22% 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
11 11
8.6 27.91% 2 Aug 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
3 3
0.66 278.79% 3 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
44 44
32.32 36.14% 4 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 4
1.74 129.89% 3 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 7 Apr 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
4 4
0.58 468.97% 5 Apr 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
5 5
2.89 73.01% 2 Mar 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
25 25
15.63 59.95% 7 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
12 12
18.23 -34.17% 2 Jan 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Nov 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
9
0.59 1359.32% 2 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Overweight
27 21
n/a n/a 2 Apr 22, 2022